By strengthening the company's fibrotic disease development pipeline, Bridge will enhance its strategic focus on the development of comprehensive treatment solutions for idiopathic pulmonary fibrosis (IPF)
The joint partnership, powered by Cloudbyz Clinical Research Management Platform and ClinChoice's industry-leading transformation services, will provide an end-to-end clinical research management technology platform and services to customers
Both companies have been selected for stand-by production by German government
Researchers from the Tel Aviv University successfully engineer the world's first 3D human spinal cord tissue transplant
Under the manufacturing agreement, Lonza will provide drug substance for Asher Bio's cis-targeted IL-2 fusion protein
The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products
BioFluidica LiquidScan harnesses the power of microfluidics
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
CanSinoBIO will continue to focus on developing a variety of innovative preventive vaccines in its diversified product pipeline with proprietary technologies, including the inhaled version of its COVID-19 vaccine, Convidecia
It is one of the 15 medical device manufacturers approved under the government’s PLI scheme
Subscribe To Our Newsletter & Stay Updated
